Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

After the FDA request, Cambridge, Massachusetts-based Sarepta said in a statement that it will continue to ship the therapy ...

Sarepta Therapeutics announced it is laying off nearly 500 employees this week, including 80 at its Easton location.

Sarepta Therapeutics announced it has laid off more than one-third of its workforce, a drastic cost-cutting move following ...

Sarepta Therapeutics to lay off 493 workers, including 80 in Ohio, amid FDA probe, stock plunge, and concerns over Duchenne gene therapy Elevidys.

A filing with the state details the Columbus job cuts for a biotech cutting more than one-third of its workforce.

Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box warning By Gabrielle Masson Jul 16, 2025 4:59pm Sarepta Sarepta Therapeutics biotech layoffs Duchenne muscular dystrophy (DMD) ...

This week on "The Readout LOUD": Just how many employees is Sarepta Therapeutics laying off? And why did the FDA reject Ultragenyx's rare disease drug over manufacturing qualms?